Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 41 - 60 of 519 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
Relapsed/Refractory
[Protocol 13-187]
Callahan, Margaret
  • Breast Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Pilot Trial of PET Imaging with (89)Zr-DFO-Trastuzumab in Esophagogastric Cancer
[Protocol 13-165]
Carrasquillo, Jorge
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
Biological, Behavioral, and Sociodemographic Characteristics of Long-Term Survivors of Ovarian Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-224]
Carter, Jeanne
  • Ovarian Cancer
  • Survivorship
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne
  • Breast Cancer
  • Survivorship
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Study Comparing Reduced-Intensity Allogeneic Stem Cell Transplantation with Best Supportive Therapy in Older Patients with Myelodysplastic Syndromes
[Protocol 14-123]
Castro-Malaspina, Hugo
  • Hematology
    • Myelodysplastic Syndrome
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
[Protocol 14-024]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase III Study of Nivolumab versus Standard Chemotherapy as Initial Treatment for Metastatic or Recurrent Non-Small Cell Lung Cancers that Express PD-L1
[Protocol 14-095]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study of MEDI4736 in Patients with Stage IIIB-IV Non-Small Cell Lung Cancer Containing the PD-L1 Protein
[Protocol 14-103]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat
  • Breast Cancer
A Phase II Clinical Trial of Trametinib plus GSK2141795 in Patients with Melanoma Containing a Normal BRAF Gene
[Protocol 13-258]
Chapman, Paul
  • Melanoma
A Phase II Study of Dacarbazine with and without Selumetinib to Treat Metastatic Uveal Melanoma
[Protocol 14-033]
Chapman, Paul
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of LGX818 Given in a Pulsatile Schedule to Patients with Stage III or IV Melanoma with a BRAF Mutation
[Protocol 13-053]
Chapman, Paul
  • Melanoma
A Phase II Study of Crizotinib in Patients with High-Risk Uveal Melanoma
[Protocol 14-063]
Chapman, Paul
  • Melanoma
    • Melanoma of the Eye
An Expanded Access Program with Nivolumab and Ipilimumab for Patients with Inoperable or Metastatic Melanoma
[Protocol 14-200]
Chapman, Paul
  • Melanoma
A Phase II Study of Trametinib with and without GSK2141795 in Patients with Advanced Uveal Melanoma
[Protocol 13-144]
Chapman, Paul
  • Melanoma
    • Melanoma of the Eye